Caixin Global
@caixin
Award-winning journalism from China's most respected newsroom. App:
Joined January 2010
77 Following 90.8K Followers
Multinational drugmakers are returning to China’s centralized procurement program after rule changes gave originator medicines a second path to selection, though stronger price pressure still looms.
Show more
